Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Experimental and Applied Biomedical Research (EABR)
Volume 19 (2018): Issue 3 (September 2018)
Open Access
Preclinical and Clinical Evidence of Safety of Antiviral Drug with Immunomodulatory Activity
Tatiana Gennadievna Borovskaya
Tatiana Gennadievna Borovskaya
| Oct 29, 2018
Experimental and Applied Biomedical Research (EABR)
Volume 19 (2018): Issue 3 (September 2018)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Oct 29, 2018
Page range:
271 - 276
Received:
Aug 11, 2018
Accepted:
Sep 12, 2018
DOI:
https://doi.org/10.2478/sjecr-2018-0040
Keywords
antiviral drug
,
interferon inducer
,
Kagocel
,
reproductive safety
,
pediatrics
,
preclinical and clinical studies
© 2018 Tatiana Gennadievna Borovskaya, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.